ABT News

Latest ABT News

• Kalray Extends Openchip Partnership in €5m AI Accelerator Deal
  TipRanks European Auto-Generated Newsdesk · Oct 14, 2026
• Abbott Laboratories (ABT) Gets a Hold from Leerink Partners
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
• The Week That Was, The Week Ahead: Macro and Markets, October 11
  Ran Melamed · Oct 11, 2026
• Meta and SpaceX Among 517 Transactions Trump Disclosed for August
  Vince Condarcuri · Oct 8, 2026
• Abits Group Overhauls Board and Appoints New CEO After Financing Trigger
  TipRanks Auto-Generated Newsdesk · Oct 7, 2026
• Barclays Reaffirms Their Buy Rating on Abbott Laboratories (ABT)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
• Kalray updates market on share capital and voting rights structure
  TipRanks European Auto-Generated Newsdesk · Oct 6, 2026
• RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 3, 2026
• Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)
  TipRanks Newsroom · Oct 2, 2026
• Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX)
  TipRanks Newsroom · Sep 30, 2026
• Why Is Penny Stock Lakewood-Amedex Biotherapeutics (LABT) Up 20% Today?
  William White · Sep 28, 2026
• Kalray turns profitable in H1 2026 and secures strategic AI chip licences
  TipRanks European Auto-Generated Newsdesk · Sep 24, 2026
• Abits Group Secures Note Financing and $250 Million Equity Line to Bolster Capital Structure
  TipRanks Auto-Generated Newsdesk · Sep 17, 2026